Medable has added Cognizant to its Medable Partner Network, designed to help companies launch their clinical trials more quickly and run them more efficiently.
A leader from the information technology specialist explains how evolved thinking and digital transformation are leading to benefits across the industry.
The two companies are integrating their technologies in a move designed to help hasten trial launches, and get promising new treatments to market faster.
Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.
Medidata is working with Cognizant to develop a set of services that will provide pharma, biotech, CROs and others with the capabilities to “digitally transform” their research and commercialization.